期刊文献+

表皮生长因子受体对鼻咽癌放疗后细胞增殖的影响

Effect of EGFR on proliferation of nasopharyngeal carcinoma cell after chemotherapy
下载PDF
导出
摘要 目的:观察表皮生长因子受体(epidermal growth factor receptor,EGFR)对射线照射后的鼻咽癌细胞的增殖的影响。方法:用shRNA-EGFR转染人鼻咽癌细胞系CNE1,应用X射线照射转染EGFRSiRNA前后的细胞,MTT实验比较转染干扰质粒前后照射后细胞增殖变化。结果:shRNA-EGFR成功转染CNE1细胞。CNE1细胞干扰后照射较干扰前照射增殖减低。结论:通过抑制鼻咽癌细胞EGFR的表达,可以抑制鼻咽癌放疗后的增殖。 Objective. To investigate the effect of EGFR on proliferation of human nasopharyngeal carcinoma cell after chemotherapy. Methods: shRNA-EGFR as well as various controls was transfeeted into CNE1, human nasopharyngeal carcinoma cell line. The proliferation of cells after chemotherapy was detected by MTT experiment, and was compared before and after interfering. Results. shRNA-EGFR could be effectively delivered into nasopharyngeal carcinoma cells. Proliferation of CNE1 irradiated cells was significantly decreased after interference. Conclusions. The proliferation of nasopharyngeal carcinoma can be inhibited through silencing EGFR.
出处 《海南医学院学报》 CAS 2012年第9期1194-1195,1199,共3页 Journal of Hainan Medical University
基金 广东省自然科学基金项目(8451051501000519)~~
关键词 鼻咽肿瘤 表皮生长因子受体 细胞系 辐射 增殖 Epidermal .growth factor receptor Nasopharyngeal carcinoma Cell line Radiation Proliferation
  • 相关文献

参考文献11

  • 1Chua DT, Nicholls JM, Sham JS, et al. Prognostic val- ue of epidermal growth factor receptor expression in pa- tients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy [J]. Int J Radiat Oncol Biol Phys, 2004,59 ( 1): 11-20.
  • 2Kalyankrishna, Grandis J. Epidermal Growth Factor Receptor Biology in Head and Neck Cancer[J]. Clin On- eol,2006,24(17): 2666-2672.
  • 3卜俊国,张积仁,肖明星.不同分化程度鼻咽癌细胞化疗药物作用后放射敏感性的变化[J].南方医科大学学报,2006,26(8):1140-1142. 被引量:4
  • 4张永胜,卜俊国,张积仁.表皮生长因子受体shRNA对人鼻咽癌裸鼠移植瘤放射敏感性的影响[J].南方医科大学学报,2010,30(5):993-997. 被引量:5
  • 5殷蔚伯,余子豪,徐国镇,等.肿瘤放射治疗学[M].第4版.北京:中国协和医科大学出版社,2007:1350-1351.
  • 6Kim VN. Small RNAs: classification, biogenesis and function[J]. Mol Cells,2005 ,9(1) :1-15.
  • 7Tomari Y, Zamore PD. Perspective.. machines for RNAi[J]. Genes Dev,2005,19(5):517-529.
  • 8Paddison PJ, Candy AA, Bemstein E, et al. Short hair- pin RNAs(shRNAs) induce sequence specific silencing in mammalian cells[J]. Genes Dev, 2002,16948-16958.
  • 9Yarden Y. The EGFR family and its ligands in human cancer signalling mechanisms and therapeutic opportu- nities[J]. Eur J Cancer, 2001,37 (Suppl 4) : S3-8.
  • 10Ritter CA, Arteaga CL. The epidermal growth factor receptor-tyrosine kinase: a promising therapeutic target in solid tumors[J]. Semin Oncol,2003,30(1) :3-11.

二级参考文献23

  • 1McBride WH, Chiang CS, Olson JL, et al. A sense of danger from radiation[J]. Radiat Res, 2004, 1620): 1-19.
  • 2Chua DT, Nicholls JM, Sham JS, et al. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiothempy[J ]. Int J Radiat Oncol Biol Phys, 2004, 59:11-20.
  • 3Sheen TS, Huang YT, Chang YL, et al. Epstein-Barr virus-encoded latent membrane protein 1 co-expresses with epidermal growth factor receptor in nasopharyngeal carcinoma[J]. Jpn J Cancer Res, 1999, 90(12): 1285-92.
  • 4Kalyankrishna S, Grandis JR. Epidermal growth factor receptor biology in head and neck cancer[J]. Clin Oncol, 2006, 24: 2666-72.
  • 5Burtness B, Goldwasser MA, Flood W, et al. Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study [J]. J Clin Oncol, 2005, 23: 8646-54.
  • 6Herbst RS, Arquette M, Shin DM, et al. Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck[J ]. J Clin Oncol, 2005, 23: 5578-87.
  • 7Livak K J, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2^-△△CT method [J ]. Methods, 2001, 25: 402-8.
  • 8Ritter CA, Arteaga CL. The epidermal growth factor receptor-tyrosine kinase: a promising therapeutic target in solid tumors [J]. Semin Oncol, 2003, 30(1 Suppl 1): 3-11.
  • 9Mendelsohn J, Baselga J. The EGF receptor family as targets for cancer therapy[J]. Oncogene, 2000, 19(56): 6550-65.
  • 10Grunwald V, Hidalgo M. Developing inhibitors of the epidermal growth factor receptor for cancer treatment[J]. J Natl Cancer Inst, 2003, 95(12): 851-67.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部